218 related articles for article (PubMed ID: 34210686)
41. Evaluation of the intraoperative human papillomavirus test as a marker of early cure at 12 months after electrosurgical excision procedure in women with cervical high-grade squamous intraepithelial lesion: a prospective cohort study.
Rabasa J; Bradbury M; Sanchez-Iglesias JL; Guerrero D; Forcada C; Alcalde A; Pérez-Benavente A; Cabrera S; Ramon-Cajal S; Hernandez J; Dinares C; García A; Centeno C; Gil-Moreno A
BJOG; 2020 Jan; 127(1):99-105. PubMed ID: 31502397
[TBL] [Abstract][Full Text] [Related]
42. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer.
Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL
Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540
[TBL] [Abstract][Full Text] [Related]
43. Results of the c-TRAK TN trial: a clinical trial utilising ctDNA mutation tracking to detect molecular residual disease and trigger intervention in patients with moderate- and high-risk early-stage triple-negative breast cancer.
Turner NC; Swift C; Jenkins B; Kilburn L; Coakley M; Beaney M; Fox L; Goddard K; Garcia-Murillas I; Proszek P; Hall P; Harper-Wynne C; Hickish T; Kernaghan S; Macpherson IR; Okines AFC; Palmieri C; Perry S; Randle K; Snowdon C; Stobart H; Wardley AM; Wheatley D; Waters S; Winter MC; Hubank M; Allen SD; Bliss JM;
Ann Oncol; 2023 Feb; 34(2):200-211. PubMed ID: 36423745
[TBL] [Abstract][Full Text] [Related]
44. Residual and recurrent disease rates following LEEP treatment in high-grade cervical intraepithelial lesions.
Baloglu A; Uysal D; Bezircioglu I; Bicer M; Inci A
Arch Gynecol Obstet; 2010 Jul; 282(1):69-73. PubMed ID: 19940997
[TBL] [Abstract][Full Text] [Related]
45. Viral-Cellular DNA Junctions as Molecular Markers for Assessing Intra-Tumor Heterogeneity in Cervical Cancer and for the Detection of Circulating Tumor DNA.
Carow K; Gölitz M; Wolf M; Häfner N; Jansen L; Hoyer H; Schwarz E; Runnebaum IB; Dürst M
Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937589
[TBL] [Abstract][Full Text] [Related]
46. The role of human papillomavirus genotyping for detecting high-grade intraepithelial neoplasia or cancer in HPV-positive women with normal cytology: a study from a hospital in northeastern China.
Zhang J; Zhang D; Yang Z; Wang X; Wang D
BMC Cancer; 2020 May; 20(1):443. PubMed ID: 32429919
[TBL] [Abstract][Full Text] [Related]
47. HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.
Leung E; Han K; Zou J; Zhao Z; Zheng Y; Wang TT; Rostami A; Siu LL; Pugh TJ; Bratman SV
Clin Cancer Res; 2021 Nov; 27(21):5857-5868. PubMed ID: 34580115
[TBL] [Abstract][Full Text] [Related]
48. Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences.
Henriksen TV; Tarazona N; Frydendahl A; Reinert T; Gimeno-Valiente F; Carbonell-Asins JA; Sharma S; Renner D; Hafez D; Roda D; Huerta M; Roselló S; Madsen AH; Løve US; Andersen PV; Thorlacius-Ussing O; Iversen LH; Gotschalck KA; Sethi H; Aleshin A; Cervantes A; Andersen CL
Clin Cancer Res; 2022 Feb; 28(3):507-517. PubMed ID: 34625408
[TBL] [Abstract][Full Text] [Related]
49. A Phase 1 Trial Assessing the Safety and Tolerability of a Therapeutic DNA Vaccination Against HPV16 and HPV18 E6/E7 Oncogenes After Chemoradiation for Cervical Cancer.
Hasan Y; Furtado L; Tergas A; Lee N; Brooks R; McCall A; Golden D; Jolly S; Fleming G; Morrow M; Kraynyak K; Sylvester A; Arif F; Levin M; Schwartz D; Boyer J; Skolnik J; Esser M; Kumar R; Bagarazzi M; Weichselbaum R; Spiotto M
Int J Radiat Oncol Biol Phys; 2020 Jul; 107(3):487-498. PubMed ID: 32151670
[TBL] [Abstract][Full Text] [Related]
50. Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
Yang J; Gong Y; Lam VK; Shi Y; Guan Y; Zhang Y; Ji L; Chen Y; Zhao Y; Qian F; Chen J; Li P; Zhang F; Wang J; Zhang X; Yang L; Kopetz S; Futreal PA; Zhang J; Yi X; Xia X; Yu P
Cell Death Dis; 2020 May; 11(5):346. PubMed ID: 32393783
[TBL] [Abstract][Full Text] [Related]
51. Human papillomavirus type 18: association with poor prognosis in early stage cervical cancer.
Burger RA; Monk BJ; Kurosaki T; Anton-Culver H; Vasilev SA; Berman ML; Wilczynski SP
J Natl Cancer Inst; 1996 Oct; 88(19):1361-8. PubMed ID: 8827013
[TBL] [Abstract][Full Text] [Related]
52. Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.
Hanna GJ; Sridharan V; Margalit DN; La Follette SK; Chau NG; Rabinowits G; Lorch JH; Haddad RI; Tishler RB; Anderson KS; Schoenfeld JD
Cancer Biomark; 2017; 19(2):129-136. PubMed ID: 28387659
[TBL] [Abstract][Full Text] [Related]
53. Prognostic significance of high-risk HPV status in advanced cervical cancers and pelvic lymph nodes.
Füle T; Csapó Z; Máthé M; Tátrai P; László V; Papp Z; Kovalszky I
Gynecol Oncol; 2006 Mar; 100(3):570-8. PubMed ID: 16325245
[TBL] [Abstract][Full Text] [Related]
54. E6 and E7 Antibody Levels Are Potential Biomarkers of Recurrence in Patients with Advanced-Stage Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.
Spector ME; Sacco AG; Bellile E; Taylor JMG; Jones T; Sun K; Brown WC; Birkeland AC; Bradford CR; Wolf GT; Prince ME; Moyer JS; Malloy K; Swiecicki P; Eisbruch A; McHugh JB; Chepeha DB; Rozek L; Worden FP
Clin Cancer Res; 2017 Jun; 23(11):2723-2729. PubMed ID: 27872102
[No Abstract] [Full Text] [Related]
55. Development of a Multiplex PCR Test with Automated Genotyping Targeting E7 for Detection of Six High-Risk Human Papillomaviruses.
Paes EF; de Assis AM; Teixeira CS; Aoki FH; Teixeira JC
PLoS One; 2015; 10(6):e0130226. PubMed ID: 26087285
[TBL] [Abstract][Full Text] [Related]
56. Methylation of HPV18, HPV31, and HPV45 genomes and cervical intraepithelial neoplasia grade 3.
Wentzensen N; Sun C; Ghosh A; Kinney W; Mirabello L; Wacholder S; Shaber R; LaMere B; Clarke M; Lorincz AT; Castle PE; Schiffman M; Burk RD
J Natl Cancer Inst; 2012 Nov; 104(22):1738-49. PubMed ID: 23093560
[TBL] [Abstract][Full Text] [Related]
57. Physical status of human papillomavirus integration in cervical cancer is associated with treatment outcome of the patients treated with radiotherapy.
Shin HJ; Joo J; Yoon JH; Yoo CW; Kim JY
PLoS One; 2014; 9(1):e78995. PubMed ID: 24427262
[TBL] [Abstract][Full Text] [Related]
58. Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases.
Chen P; Zhang W; Yang D; Zhang W; Gao S
Med Sci Monit; 2019 Mar; 25():1894-1902. PubMed ID: 30864560
[TBL] [Abstract][Full Text] [Related]
59. Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy.
Damerla RR; Lee NY; You D; Soni R; Shah R; Reyngold M; Katabi N; Wu V; McBride SM; Tsai CJ; Riaz N; Powell SN; Babady NE; Viale A; Higginson DS
JCO Precis Oncol; 2019; 3():. PubMed ID: 31485558
[TBL] [Abstract][Full Text] [Related]
60. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
